Related Experiment Videos
Pre-cancers and liability to other diseases
British Journal of Cancer
|March 1, 1978
Summary
Reticuloendothelial system (RES) neoplasms can impair immunity before detection, complicating prevalence studies. High infection rates in populations like A-bomb survivors make them unsuitable for studying radiation and cancer links.
Area of Science:
- Oncology
- Immunology
- Radiation Epidemiology
Background:
- Reticuloendothelial system (RES) neoplasms can precede clinical recognition.
- Early immunological impairment from RES neoplasms can have lethal consequences.
- Accurate prevalence of RES neoplasms is challenging in infection-prone populations.
Purpose of the Study:
- To investigate the challenges in identifying the true prevalence of RES neoplasms.
- To evaluate the suitability of A-bomb survivor populations for radiation-cancer association studies.
Main Methods:
- Analysis of 10,556 case-control pairs from the Oxford Survey of Childhood Cancers.
- Assessment of early immunological competence loss in relation to RES neoplasms.
- Evaluation of infection death rates in specific populations.
Main Results:
- RES neoplasms are associated with pre-clinical loss of immunological competence.
- High infection death rates, such as those post-nuclear holocaust, obscure RES neoplasm prevalence.
- A-bomb survivor populations exhibit high infection rates, confounding radiation-cancer research.
Conclusions:
- The study highlights difficulties in determining RES neoplasm prevalence due to early immune effects.
- Ionizing radiation and human cancer associations cannot be reliably studied in populations with high infection mortality.
- Further research is needed to understand RES neoplasms and immune function independently of confounding factors.